Risk- and non-risk-associated variants at the 10q26 AMD locus influence ARMS2 mRNA expression but exclude pathogenic effects due to protein deficiency.
Fifteen variants in 10q26 are in strong linkage disequilibrium and are associated with an increased risk for age-related macular degeneration (AMD), a frequent cause of blindness in developed countries. These variants tag a single-risk haplotype encompassing the genes ARMS2 (age-related maculopathy susceptibility 2) and part of HTRA1 (HtrA serine peptidase 1). To define the true AMD susceptibility gene in 10q26, several studies have focused on the influence of risk alleles on the expression of ARMS2 and/or HTRA1, but the results have been inconsistent. By heterologous expression of genomic ARMS2 variants, we now show that ARMS2 mRNA levels transcribed from the risk haplotype are significantly reduced compared with non-risk mRNA isoforms. Analyzing variant ARMS2 constructs, this effect could specifically be assigned to the known insertion/deletion polymorphism (c.(*)372_815del443ins54) in the 3'-untranslated region of ARMS2. Reporter gene assays with HTRA1 promoter sequences demonstrated the presence of a Müller glia-specific cis-regulatory region further upstream of the transcription start site. However, AMD risk alleles had little or no effect on HTRA1 promoter activity in the retina. Analysis of a large series of human post-mortem retina/retinal pigment epithelial samples heterozygous for the risk haplotype confirmed the in vitro/ex vivo results and demonstrated that the risk haplotype affects ARMS2 but not HTRA1 mRNA expression. Furthermore, we provide in vivo evidence that a common non-risk-associated non-synonymous variant (rs2736911) also leads to decreased ARMS2 transcript levels. Consequently, our data suggest that pathogenic effects due to ARMS2 protein deficiency are unlikely to account for AMD pathology.
Institute of Human Genetics, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.
Ulrike
U
Friedrich
Connie A
CA
Myers
Lars G
LG
Fritsche
Andrea
A
Milenkovich
Armin
A
Wolf
Joseph C
JC
Corbo
Bernhard H F
BH
Weber
D020413:3' Untranslated Regions / Q000235:genetics; D000483:Alleles; D002460:Cell Line; D002879:Chromosomes, Human, Pair 10; D005786:Gene Expression Regulation; D056426:Genetic Loci; D020022:Genetic Predisposition to Disease; D006579:Heterozygote; D000074289:High-Temperature Requirement A Serine Peptidase 1; D006801:Humans; D008268:Macular Degeneration / Q000235:genetics / Q000378:metabolism*; D011110:Polymorphism, Genetic; D011506:Proteins / Q000235:genetics / Q000378:metabolism*; D012307:Risk Factors; D012697:Serine Endopeptidases / Q000235:genetics / Q000378:metabolism
D020413:3' Untranslated Regions; C514392:ARMS2 protein, human; D011506:Proteins; D000074289:High-Temperature Requirement A Serine Peptidase 1; C474012:HTRA1 protein, human; D012697:Serine Endopeptidases
Annu Rev Genomics Hum Genet. 2009;10:19-43
19405847
Hum Genet. 2010 Mar;127(5):595-602
20182747
Arch Ophthalmol. 2010 Mar;128(3):349-58
20212207
Science. 2002 Jun 21;296(5576):2225-9
12029063
J Comp Neurol. 2008 Jul 10;509(2):225-38
18465787
Arch Ophthalmol. 2004 Apr;122(4):564-72
15078675
Am J Hum Genet. 2005 Sep;77(3):389-407
16080115
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):79-88
19696174
Nucleic Acids Res. 2006 Jan 03;33(22):7138-50
16391004
Bioinformatics. 2005 Jan 15;21(2):263-5
15297300
Science. 2006 Nov 10;314(5801):989-92
17053108
Nat Genet. 2008 Jul;40(7):820-1
18583975
Curr Cancer Drug Targets. 2009 Jun;9(4):451-68
19519315
Nat Genet. 2006 Sep;38(9):1055-9
16936732
Mol Vis. 2010 Jul 15;16:1317-23
20664794
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16227-32
17884985
Nat Genet. 2008 Jul;40(7):892-6
18511946
Science. 2005 Apr 15;308(5720):419-21
15761120
Nat Genet. 2006 Oct;38(10):1173-7
16998489
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32
15870199
Science. 2005 Apr 15;308(5720):385-9
15761122
PLoS One. 2008 May 21;3(5):e2199
18493315
Mol Cancer Res. 2010 Sep;8(9):1248-60
20671064
Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3379-86
20207970
PLoS Genet. 2010 Feb 05;6(2):e1000836
20140183
Gene. 2005 Nov 21;361:13-37
16213112
Gene Ther. 2010 Nov;17(11):1390-9
20463752
Eur J Hum Genet. 2009 Jan;17(1):100-4
18685559
Nat Rev Mol Cell Biol. 2007 Feb;8(2):113-26
17245413
N Engl J Med. 2007 Aug 9;357(6):553-61
17634448
Hum Mol Genet. 2005 Nov 1;14(21):3227-36
16174643
N Engl J Med. 2010 Oct 21;363(17):1648-55
20961248
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):16-22
14603031
Hum Mol Genet. 2007 Aug 15;16(16):1986-92
17576744
Am J Hum Genet. 2003 Sep;73(3):540-50
12900797
J Immunol. 2010 Sep 15;185(6):3379-90
20709948
Science. 2000 Mar 31;287(5462):2486-92
10741968
Science. 2006 Nov 10;314(5801):992-3
17053109
Nat Genet. 2007 Oct;39(10):1200-1
17767156
Mol Vis. 2008;14:2263-71
19065273
Am J Hum Genet. 1998 Jul;63(1):200-6
9634502
Histol Histopathol. 2010 May;25(5):599-608
20238298
Am J Hum Genet. 2003 Oct;73(4):780-90
12945014
Nat Genet. 2006 Apr;38(4):458-62
16518403
Hum Mol Genet. 2010 Dec 1;19(23):4694-704
20843825
Hum Mutat. 2009 Jul;30(7):1048-53
19384966
Mol Vis. 2004 Jan 26;10:57-61
14758336
Science. 2005 Apr 15;308(5720):421-4
15761121
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3084-90
19255159
Oncogene. 2004 Feb 26;23(8):1636-44
14716297
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7401-6
20385819
J Histochem Cytochem. 2004 Dec;52(12):1609-17
15557215